HIV-, HCV-, and Co-Infections and Associated Risk Factors among Drug Users in Southwestern China: A Township-Level Ecological Study Incorporating Spatial Regression
Background The human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are major public health problems. Many studies have been performed to investigate the association between demographic and behavioral factors and HIV or HCV infection. However, some of the results of these studies have been in conflict. Methodology/Principal Findings The data of all entrants in the 11 national methadone clinics in the Yi Autonomous Prefecture from March 2004 to December 2012 were collected from the national database. Several spatial regression models were used to analyze specific community characteristics associated with the prevalence of HIV and HCV infection at the township level. The study enrolled 6,417 adult patients. The prevalence of HIV infection, HCV infection and co-infection was 25.4%, 30.9%, and 11.0%, respectively. Prevalence exhibited stark geographical variations in the area studied. The four regression models showed Yi ethnicity to be associated with both the prevalence of HIV and of HIV/HCV co-infection. The male drug users in some northwestern counties had greater odds of being infected with HIV than female drug users, but the opposite was observed in some eastern counties. The ‘being in drug rehabilitation variable was found to be positively associated with prevalence of HCV infection in some southern townships, however, it was found to be negatively associated with it in some northern townships. Conclusions/Significance The spatial modeling creates better representations of data such that public health interventions must focus on areas with high frequency of HIV/HCV to prevent further transmission of both HIV and HCV.
References
[1]
Kim AY, Onofrey S, Church DR (2013) An epidemiologicupdate on hepatitis C infection in persons living with or at risk of HIV infection. J Infect Dis 207 Suppl 1)S1–6. doi: 10.1093/infdis/jis927
[2]
De Cock KM, Jaffe HW, Curran JW (2012) The evolving epidemiology of HIV/AIDS. AIDS 26: 1205–1213. doi: 10.1097/qad.0b013e328354622a
[3]
Strader DB (2005) Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clin Infect Dis 41 Suppl 1S7–13. doi: 10.1086/429489
[4]
Koziel MJ, Peters MG (2007) Viral hepatitis in HIV infection. N Engl J Med 356: 1445–1454. doi: 10.1056/nejmra065142
[5]
Sherman KE, Rouster SD, Chung RT, Rajicic N (2002) Hepatitis C virusprevalence among patients infected with human immunodeficiencyvirus: a cross-sectional analysis of the US adult AIDS Clinical TrialsGroup. Clin Infect Dis 34: 831–837. doi: 10.1086/339042
[6]
Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, et al. (2008) Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS One 3: e3608. doi: 10.1371/journal.pone.0003608
[7]
Maier I, Wu GY (2002) Hepatitis C and HIV co-infection: a review. World J Gastroenterol 8: 577–579.
[8]
Aceijas C, Rhodes T (2007) Global estimates of prevalence of HCV infectionamong injecting drug users. Int J Drug Policy 18: 352–358. doi: 10.1016/j.drugpo.2007.04.004
[9]
Abdool Karim SS (2009) Commentary: Spatial clustering of HIV infection: providing clues for effective HIV prevention. Int J Epidemiol 38: 1016–1017. doi: 10.1093/ije/dyp201
[10]
Tanser F, B？rnighausen T, Cooke GS, Newell ML (2009) Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. Int J Epidemiol 38: 1008–1016. doi: 10.1093/ije/dyp148
[11]
Messina JP, Emch M, Muwonga J, Mwandagalirwa K, Edidi SB, et al. (2010) Spatial and socio-behavioral patterns of HIV prevalence in the Democratic Republic of Congo. SocSci Med 71: 1428–1435. doi: 10.1016/j.socscimed.2010.07.025
[12]
Cuadros DF, Awad SF, Abu-Raddad LJ (2013) Mapping HIV clustering: a strategy for identifying populations at high risk of HIV infection in sub-Saharan Africa. Int J Health Geogr 12: 28. doi: 10.1186/1476-072x-12-28
[13]
Zhuang X, Wang Y, Chow EP, Liang Y, Wilson DP, et al. (2012) Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis. Drug Alcohol Depend126: 286–295. doi: 10.1016/j.drugalcdep.2012.05.028
[14]
Yen YF, Yen MY, Su LW, Li LH, Chuang P (2012) Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan. BMC Public Health 12: 1066. doi: 10.1186/1471-2458-12-1066
[15]
Kretzschmar M, Zhang W, Mikolajczyk RT, Wang L, Sun X, et al. (2008) Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? BMC Infect Dis 8: 108. doi: 10.1186/1471-2334-8-108
[16]
Weidmann C, Schneider S, Litaker D, Weck E, Klüter H (2012) A spatial regression analysis of German community characteristics associated with voluntary non-remunerated blood donor rates. Vox Sang 102: 47–54. doi: 10.1111/j.1423-0410.2011.01501.x
[17]
Pang L, Hao Y, Mi G, Wang C, Luo W, et al. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS 21 Suppl 8S103–107. doi: 10.1097/01.aids.0000304704.71917.64
[18]
Yin W, Hao Y, Sun X, Gong X, Li F, et al. (2010) Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol 39 Suppl 2ii29–37. doi: 10.1093/ije/dyq210
[19]
Du WJ, Xiang YT, Wang ZM, Chi Y, Zheng Y, et al. (2008) Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. Drug Alcohol Depend 94: 158–164. doi: 10.1016/j.drugalcdep.2007.11.009
[20]
Anselin L, Kim YW, Syabri I (2004) Web-based analytical tools for the exploration of spatial data. J Geogr Syst 6: 197–218. doi: 10.1007/s10109-004-0132-5
[21]
Anselin L, Syabri I, Kho Y (2006) GeoDa, an introduction to spatial data analysis. Geographical Analysis 38: 5–22. doi: 10.1111/j.0016-7363.2005.00671.x
[22]
Bivand R (2006) Implementing spatial data analysis software in R. Geographical Analysis. 38: 23–40. doi: 10.1111/j.0016-7363.2005.00672.x
[23]
Rey SJ, Janikas MV (2006) STARS: Space-time analysis of regional systems. Geographical Analysis 38: 67–86. doi: 10.1111/j.0016-7363.2005.00675.x
[24]
Hu Z, Rao KR (2009) Particulate air pollution and chronic ischemic heart disease in the eastern United States: a county level ecological study using satellite aerosol data. Environ Health 8: 26. doi: 10.1186/1476-069x-8-26
[25]
Conley JF (2011) Estimation of exposure to toxic releases using spatial interaction modeling. Int J Health Geogr 10: 20. doi: 10.1186/1476-072x-10-20
[26]
Kelejian HH, Prucha IR (1998) A Generalized Spatial Two-Stage Least Squares Procedures for Estimating a Spatial Autoregressive Model with Autoregressive Disturbances. J Real Estate Finan Econ 17: 99–121.
[27]
Kelejian HH, Prucha IR (1999) A Generalized Moments Estimator for the Autoregressive Parameter in a Spatial Model. Int Econ Rev 40: 509–533. doi: 10.1111/1468-2354.00027
[28]
Arraiz I, Drukker DM, Kelejian HH, Prucha IR (2010) “A Spatial Cliff-Ord-type Model with Heteroscedastic Innovations: Small and Large Sample Results.”. J Regional Sci 50: 592–614. doi: 10.1111/j.1467-9787.2009.00618.x
[29]
Kelejian HH, Prucha IR (2007) “HAC Estimation in a Spatial Framework.”. J Econometrics 140: 131–154. doi: 10.1016/j.jeconom.2006.09.005
[30]
Buse K, Dickinson C, Sidibé M (2008) HIV: know your epidemic, act on its politics. JRSM 101: 572–573. doi: 10.1258/jrsm.2008.08k036
[31]
Wilson D, Halperin DT (2008) "Know your epidemic, know your response": a useful approach, if we get it right. Lancet 372: 423–426.
[32]
Fang YX, Wang YB, Shi J, Liu ZM, Lu L (2006) Recent trends in drug abuse in China. Acta Pharmacol Sin 27: 140–144. doi: 10.1111/j.1745-7254.2006.00270.x
[33]
Qian HZ, Hao C, Ruan Y, Cassell HM, Chen K, et al. (2008) Impact of methadone on drug use and risky sex in China. J Subst Abuse Treat 34: 391–7. doi: 10.1016/j.jsat.2007.07.002
[34]
Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D (2001) Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med 161: 1281–1288. doi: 10.1001/archinte.161.10.1281
[35]
Gaskin S, Brazil C, Pickering D (2000) The sharing of injecting paraphernalia by intravenous drug users (IDUs) within a Worcestershire cohort, with specific reference to water and filters. Int J Drug Policy 11: 423–435. doi: 10.1016/s0955-3959(00)00069-4
[36]
Booth RE, Campbell BK, Mikulich-Gilbertson SK, Tillotson CJ, Choi D, et al. (2011) Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS Behav 15: 30–44. doi: 10.1007/s10461-010-9751-7
[37]
Chen HT, Tuner N, Chen CJ, Lin HY, Liang S, et al. (2013) Correlations between compulsory drug abstinence treatments and HIV risk behaviors among injection drug users in a border city of South China. AIDS Educ Prev 25: 336–348. doi: 10.1521/aeap.2013.25.4.336
[38]
Dai S, Shen Z, Zha Z, Leng R, Qin W, et al. (2012) Seroprevalence of HIV, syphilis, and hepatitis C virus in the general population of the Liangshan Prefecture, Sichuan Province, China. J Med Virol 84(1): 1–5. doi: 10.1002/jmv.22214
[39]
Choi SY, Cheung YW, Chen K (2006) Gender and HIV risk behavior among intravenous drug users in Sichuan Province, China. SocSci Med 62: 1672–1684. doi: 10.1016/j.socscimed.2005.08.046
[40]
Yang Y, Luan RS, Liu P, Wu CL, Zhou Y, et al. (2012) Casual sex and concurrent sexual partnerships among young people from an Yi community with a high prevalence of HIV in China. Asian J Androl 14: 758–765. doi: 10.1038/aja.2012.25
[41]
Davies AG, Dominy NJ, Peters AD, Richardson AM (1996) Gender differences in HIV risk behaviour of injecting drug users in Edinburgh. AIDS Care 8: 517–527. doi: 10.1080/09540129650125489
[42]
Susser M (1994) The logic in ecological: I. The logic of analysis. Am J Public Health 84: 825–829. doi: 10.2105/ajph.84.5.825
